Cardiol Therapeutics Inc. (CRDL) vs Freenome, Inc. (FRNM)

A side-by-side comparison of Cardiol Therapeutics Inc. and Freenome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CRDL

Cardiol Therapeutics Inc.

$154M

$1.34HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT

FRNM

Freenome, Inc.

$136M

$16.68HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT

Total return — CRDL vs FRNM

growth of $100 · dividends reinvested · last 1y

CRDL +24.5% (+24.5%/yr)FRNM +52.9% (+52.9%/yr)FRNM compounded faster over this window

CRDL FRNM

Metrics side by side

Total return (annualized)

Metric	CRDL	FRNM
Total return (1Y)	23.24%	N/A
Total return CAGR (3Y)	19.11%	N/A
Total return CAGR (5Y)	-18.36%	N/A

FRNM is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CRDL analysis Full FRNM analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.